The Time Has Come: 4 Gene Therapy Stocks to Buy, 1 to Avoid

An analyst at Raymond James¬†warns that while gene therapy stocks have taken off like a rocket, not all gene therapies are equal. The firm launched coverage on 5 stocks, declaring that “the gene therapy era as arrived.”¬†
Source: Barrons

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>